Anxiety Disorders
📧 Sign up to get email alerts when something new happens for Anxiety Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Anxiety of Patient and His Partner During Admission to Emergency Department
This clinical trial update describes anxiety experienced by a patient and their partner during admission to the emergency department, sponso…
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Hypnotherapy in Treating Chronic Pain in Cancer Survivors [NA]
The clinical trial evaluating hypnotherapy for chronic pain in cancer survivors has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Psychosocial and Medication Treatment for Anxiety in Alcoholism [Phase 2, Phase 3]
Clinical trial update for psychosocial and medication treatment targeting anxiety in alcoholism shows completed status with results posted (…
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: Therapeutic Listening in Patients With Colorectal Cancer [NA]
A completed clinical trial from the University of Sao Paulo evaluating Therapeutic Listening as an intervention for anxiety and fear in pati…
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Attention Bias Modification Training for Child Anxiety CBT Nonresponders [NA]
A completed clinical trial evaluated Attention Bias Modification Training for children with anxiety who did not respond to CBT; results have…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: First Study in Humans With GSK424887 [Phase 1]
GlaxoSmithKline's GSK424887 completed its first-in-human Phase 1 trial in individuals with depressive and anxiety disorders.
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: First Study in Humans With GSK206136 [Phase 1]
This document reports the first-in-human Phase 1 study of GSK206136. The trial investigating depressive disorder and anxiety disorders has c…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas [NA]
A completed clinical trial assessing telehealth-delivered mental health services for children in underserved primary care settings. The stud…
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: PRIME: Cognitive Outcome Following Major Burns
The PRIME trial evaluating cognitive outcomes after major burns has completed, examining cognitive function, brain inflammation, quality of …
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity [Phase 4]
A Phase 4 trial evaluating lisdexamfetamine dimesylate for adults with ADHD and co-occurring anxiety and depressive disorders has been compl…
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: Cognitive Behavioral Therapy With Parental Involvement for Treating Children With Anxiety Disorders [NA]
This clinical trial update describes a study evaluating cognitive behavioral therapy with parental involvement for treating anxiety disorder…
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: FMT Treating Constipation Patients With Depression and/or Anxiety Symptoms - Clinical Efficacy and Potential Mechanisms [NA]
This clinical trial update discusses using fecal microbiota transplantation (FMT) to treat functional constipation in patients with depressi…
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: First Time in Human Study [Phase 1]
First-in-human Phase 1 trial for depressive and anxiety disorders sponsored by GlaxoSmithKline has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Using the PHQ-9 and GAD-7 as Feedback Instruments in Brief Psychotherapy [NA]
A completed clinical trial evaluating using PHQ-9 and GAD-7 scores as feedback in brief psychotherapy.
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Effectiveness of Play Interventions on Anxiety Among Hospitalized Children [NA]
The trial evaluated the effectiveness of play interventions to reduce anxiety in hospitalized children and has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Effect of Nature Based Sounds' Intervention on Agitation and Anxiety of Patients Admitted in Intensive Care Units. [NA]
Completed clinical trial evaluating whether nature-based sounds reduce agitation and anxiety in ICU patients.
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Pilot Study of Asynchronous and Synchronous Telepsychiatry for Skilled Nursing Facilities [NA]
A completed pilot study evaluating asynchronous and synchronous telepsychiatry in skilled nursing facilities for dementia and related mental…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Smoking Cessation for Depression and Anxiety Treatment [Phase 1]
A Phase 1 trial evaluating a smoking cessation treatment in adults with anxiety disorders and major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: PET Whole Body Distribution Studies Using [11C]CUMI
A completed PET imaging study evaluated the whole-body distribution of the radioligand [11C]CUMI. The study involved individuals with depres…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Fear Conditioning Using Computer-Generated Virtual Reality
This clinical trial update notes the completion of a study evaluating fear conditioning using computer-generated virtual reality in individu…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Bioequivalence Trial of Alprazolam 2 mg Tablets [Phase 1]
A Phase 1 bioequivalence trial of Alprazolam 2 mg tablets for anxiety disorders has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: The Impact of Giving a Massage [EARLY_Phase 1]
This early Phase 1 trial evaluated the impact of giving a massage on mental-state measures related to depression, anxiety, or stress; the st…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Bioequivalence Study of Escitalopram Tablets 10 mg [Phase 1]
GlaxoSmithKline completed a Phase 1 bioequivalence study of escitalopram 10 mg tablets for anxiety disorders.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Bioequivalence Trial of Alprazolam 0.25 mg Tablets [Phase 1]
A Phase 1 bioequivalence trial of Alprazolam 0.25 mg tablets completed for Anxiety Disorders.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Bioequivalence Trial of Alprazolam 0.5 mg Tablets [Phase 1]
Phase 1 bioequivalence trial of Alprazolam 0.5 mg tablets completed.